HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000

Reuters
2025/11/13
HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000

HealthWarehouse.com Inc. reported net sales of $8.4 million for the third quarter ended September 30, 2025, a 7.0% decrease compared to the same period in 2024. The company recorded a net loss of $0.1 million and Adjusted EBITDA of $0.3 million for the quarter. Year-to-date sales totaled $39.1 million, representing a 97.0% increase over the prior year, with net income of $0.3 million and Adjusted EBITDA of $1.4 million. The company attributed the quarterly sales decline to slower direct-to-consumer sales and reduced sales of compounded GLP-1 prescription medications following changes in FDA approvals. HealthWarehouse.com highlighted positive cash flow and upcoming new product launches aimed at diversifying its catalog.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251112710392) on November 12, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10